The global market for Lignocaine is expected to grow at a significant CAGR during the forecast period (2021-2027). Lignocaine, commonly known as xylocaine or lidocaine, is a numbing agent used to numb a specific region of tissue (local anaesthetic). It's also utilized for nerve blocks and to treat ventricular tachycardia. Lignocaine is offered as a combination with a low amount of adrenaline (epinephrine) to allow for higher numbing dosages, less bleeding, and a longer-lasting numbing effect. It usually starts acting in four minutes and lasts for half an hour to three hours when taken as an injection. To numb the region, Lignocaine mixes can be administered directly to the skin or mucous membranes. The World Health Organization's List of Essential Medications that includes the most effective and safe medicines required in a health system, includes lignocaine. 

The increasing number of surgical operations including dental procedures, aesthetic surgery, and plastic surgeries conducted globally is anticipated to grow. The rise in chronic and acute pain problems throughout the world, as well as the economical advantages connected with lignocaine hydrochloride, are some of the key reasons driving the market growth. Due to an increase in the number of surgical operations, a prominent trend in the market is a significant increase in the need for postoperative pain management alternatives. The demand for lignocaine hydrochloride is anticipated to continue to rise as a result of this trend. According to research "Postoperative Pain Control", by NCBI around 75% of individuals who undergo surgery endure acute postoperative pain that is frequently moderate to severe in intensity, driving the overall growth of the market.

Lignocaine patches are also available to relieve chronic and acute pain. Lignocaine patches have been suggested as first-line therapy for the treatment of neuropathic pain in elderly patients, as well as those suffering from shingles, due to its safety profile and demonstrated efficacy, and this is likely to drive market growth over the forecast period.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered

o By Dosage Form 

o By Application

• Regions Covered

o North America

o Europe

o Asia-Pacific

o Rest of the world

• Competitive Landscape: Alanza Inc., Amphastar Pharmaceuticals, Inc., Cirondrugs, Mahendra Chemicals, Pfizer Inc.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Lignocaine Market by Segments

By Dosage Form

• Creams
• Patches
• Injectables
• Inhalable

By Application

• Local Anesthesia
• Heart Arrhythmia
• Dental Procedures
• Epilepsy

Global Lignocaine Market by Region